The US Supreme Court has upheld the constitutional rights of cannabis consumers to …

# 🔫 Clinical Perspective

Recent legal developments regarding cannabis use and firearm ownership have created a complex intersection that clinicians should understand when assessing patients’ social histories and risk factors. While the legal landscape continues to evolve, healthcare providers should recognize that cannabis users may have incentives to underreport or conceal their use if they perceive it affects their legal rights, potentially compromising the accuracy of substance use screening. This underreporting could obscure important clinical information relevant to mental health assessment, medication interactions, and occupational or safety-related risk stratification. Clinicians should maintain awareness that legal status of substances and regulatory barriers may influence patient disclosure, and consider creating a supportive clinical environment that prioritizes harm reduction and evidence-based assessment regardless of changing legal frameworks. When documenting cannabis use in the medical record, providers should focus on clinical impact and safety implications rather than legal consequences, while remaining informed about evolving regulations that may affect patient autonomy